Current and Future Therapeutical Aspects of X-Linked Hypophosphatemia in Children With Special Attention to Klotho/Fibroblast Growth Factor 23 System

被引：0
|
作者：
Bittmann, Stefan [1 ,2 ]
Moschuring-Alieva, Elena [1 ]
Luchter, Elisabeth [1 ]
Villalon, Gloria [1 ]
机构：
[1] Ped Mind Inst, Dept Pediat, Hindenburgring 4, D-48599 Gronau, Germany
[2] Ped Mind Inst, Med & Financial Ctr Epe, D-48599 Gronau, Germany
来源：
JOURNAL OF CLINICAL MEDICINE RESEARCH-CANADA | 2022年 / 14卷 / 10期
关键词：
KLOTHO; BUROSUMAB; MUTATION; DISEASE; FGF23; XLH;
D O I：
10.14740/jocmr4820
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：436 / 439
页数：4
相关论文
共 50 条
  • [1] Iron and fibroblast growth factor 23 in X-linked hypophosphatemia
    Imel, Erik A.
    Gray, Arnie K.
    Padgett, Leah R.
    Econs, Michael J.
    BONE, 2014, 60 : 87 - 92
  • [2] Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia
    Kida, Y
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (05): : 505 - 505
  • [3] X-linked hypophosphatemia, fibroblast growth factor 23 signaling, and craniosynostosis
    Grimbly, Chelsey
    Graf, Daniel
    Ward, Leanne M.
    Alexander, R. Todd
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2023, 248 (22) : 2175 - 2182
  • [4] Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.
    Jonsson, KB
    Zahradnik, R
    Larsson, T
    White, KE
    Sugimoto, T
    Imanishi, Y
    Yamamoto, T
    Hampson, G
    Koshiyama, H
    Ljunggren, Ö
    Oba, K
    Yang, IM
    Miyauchi, A
    Econs, MJ
    Lavigne, J
    Jüppner, H
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (17): : 1656 - 1663
  • [5] Dental impact of anti-fibroblast growth factor 23 therapy in X-linked hypophosphatemia
    dos Santos, Elis J. Lira
    Nakajima, Kenta
    Po, Julien
    Hanai, Ayako
    Zhukouskaya, Volha
    Duplan, Martin Biosse
    Linglart, Agnes
    Shimada, Takashi
    Chaussain, Catherine
    Bardet, Claire
    INTERNATIONAL JOURNAL OF ORAL SCIENCE, 2023, 15 (01)
  • [6] Fibroblast growth factor-23: The phosphatonin essential to the pathogenesis of X-linked hypophosphatemia (XLH).
    Yuan, B.
    Takaiwa, M.
    Clemens, T. L.
    Hedge, A.
    Rowe, P. S. N.
    Kumar, R.
    Feng, J. Q.
    Drezner, M. K.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S11 - S11
  • [7] Dental impact of anti-fibroblast growth factor 23 therapy in X-linked hypophosphatemia
    Elis J.Lira dos Santos
    Kenta Nakajima
    Julien Po
    Ayako Hanai
    Volha Zhukouskaya
    Martin Biosse Duplan
    Agnès Linglart
    Takashi Shimada
    Catherine Chaussain
    Claire Bardet
    International Journal of Oral Science, 2023, (04) : 691 - 700
  • [8] Dental impact of anti-fibroblast growth factor 23 therapy in X-linked hypophosphatemia
    Elis J. Lira dos Santos
    Kenta Nakajima
    Julien Po
    Ayako Hanai
    Volha Zhukouskaya
    Martin Biosse Duplan
    Agnès Linglart
    Takashi Shimada
    Catherine Chaussain
    Claire Bardet
    International Journal of Oral Science, 15
  • [9] Treatment of X-Linked Hypophosphatemia with Calcitriol and Phosphate Increases Circulating Fibroblast Growth Factor 23 Concentrations
    Imel, Erik A.
    DiMeglio, Linda A.
    Hui, Siu L.
    Carpenter, Thomas O.
    Econs, Michael J.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (04): : 1846 - 1850
  • [10] Growth Curves for Children with X-linked Hypophosphatemia
    Mao, Meng
    Carpenter, Thomas O.
    Whyte, Michael P.
    Skrinar, Alison
    Chen, Chao-Yin
    San Martin, Javier
    Rogol, Alan D.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (10): : 3243 - 3249
12345